Modulation of brain dopamine transmission by sex steroids

Reviews in the Neurosciences

Volumn 5, Issue 1, 1994, Pages 27-42

  Paolo, Therese Di ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

brain; dopamine; estrogen; estrous cycle; progesterone; steroids; striatum

Indexed keywords

APOMORPHINE; COCAINE; DOMPERIDONE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; DRONABINOL; ESTROGEN; LEVODOPA; NEUROLEPTIC AGENT; PROGESTERONE; SEX HORMONE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; BASAL GANGLION; BEHAVIOR; COGNITION; CORPUS STRIATUM; DOPAMINERGIC ACTIVITY; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; ELECTROENCEPHALOGRAM; ESTRUS CYCLE; EXTRAPYRAMIDAL SYNDROME; FEMALE; GILLES DE LA TOURETTE SYNDROME; HUMAN; HYPOTHALAMUS; MALE; MONKEY; MOTOR PERFORMANCE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; REVIEW; SCHIZOPHRENIA; SEX DIFFERENCE; SIDE EFFECT; STEROID THERAPY;

ANIMAL; BRAIN; DOPAMINE; HUMAN; SEX HORMONES; SYNAPTIC TRANSMISSION;

EID: 0028258221     PISSN: 03341763     EISSN: 21910200     Source Type: Journal    
DOI: 10.1515/REVNEURO.1994.5.1.27     Document Type: Article

References (131)

1. Abolfathi Z, Di Paolo T. Modulation of dopamine receptor agonist binding sites by cations and estradiol in intact pituitary and 7315a tumors. Biochem Pharmacol 1991; 42: 2163–2169.
2. Angermeyer MC, Kuhn L. Gender differences in age at onset of schizophrenia: an overview. Eur Arch Psychiatry Neurol Sci 1988; 237: 351–364.
3. Ayd FJ Jr. Neuroleptic and extrapyramidal reactions in psychiatric patients. In: Bordeleau JM, ed, Extrapyramidal system and neuroleptics. Montreal: Editions Psychiatrique 1961; 355–363.
4. Barbaccia ML, Trabucchi M. Tardive dyskinesia: a biological approach. Prog Clin Biol Res 1979; 39: 181–193.
5. Barber PV, Arnold AG, Evans G. Recurrent hormone dependent chorea: effects of oestrogens and progestogens. Clin Endocrinol (Oxf) 1976; 5: 291–293.
6. Baulieu EE, Kelly PA. Hormones, from molecules to disease. New York: Hermann Publisher in Arts and Science, Chapman and Hall, 1990.
7. Bédard P, Boucher R, Di Paolo T, Labrie F. Biphasic effects of estradiol and domperidone on lingual dyskinesia in monkeys. Exp Neurol 1983; 82: 172–182.
8. Bedard PJ, Boucher R. Estradiol can suppress haloperidol-induced supersensitivity in dyskinetic monkeys. Neurosci Lett 1986; 64: 206–210.
9. Bedard PJ, Di Paolo T, Langelier P, Poyet P, Labrie F. Behavioral and biochemical evidence of an effect of estradiol on striatal dopamine receptors. In: Fuxe K, Gustafsson JA, Wetterberg L, eds, Steroid hormone regulation of the brain. Oxford: Pergamon Press, 1981; 331–339.
10. Bedard PJ, Langelier P, Dankova J, Villeneuve A, Di Paolo T, Barden N, Labrie F, Boissier JR, Euvrard C. Estrogens, progesterone and the extrapyramidal system. In: Poirier LJ, Sourkes TL, Bedard PJ, eds, Advances in Neurology vol 24. New York: Raven Press, 1979; 411–422.
11. Bédard PJ, Malouin F, Di Paolo T, Labrie F. Estradiol, TRH and striatal dopaminergic mechanisms. Progr Neuropsychopharmacol Biol Psychiatry 1982; 6: 555–561.
12. Bedard PJ, Boucher R, Daigle M, Di Paolo T. Physiological doses of estradiol can increase lingual dyskinesia and cerebrospinal fluid homovanillic acid in monkeys. Neurosci Lett 1985; 58: 327–331.
13. Bedard P, Di Paolo T. Modulation of dopamine sensitive dyskinesia by estradiol and prolactin in primates. In: Woodruff GN, Poat JA, Roberts J, eds, Dopaminergic systems and their regulation. London: MacMillan Press, 1986; 339–342.
14. Bedard PJ, Boucher R, Daigle M, Di Paolo T. Similar effect of estradiol and haloperidol on experimental tardive dyskinesia in monkeys. Psychoneuroendo-crinolgy 1984; 9: 375–379.
15. Bell RCH, Smith RC. Tardive dyskinesia: characterization and prevalence in statewide system. J Clin Psychiatry 1978; 39: 39–47.
16. Benbow CP. Sex differences in mathematical reasoning ability in intellectually talented preadolescents: their nature, effects, and possible causes. Behav Brain Sci 1988; 11: 169–232.
17. Bickerstaff ER. Involuntary movements. In: Bickerstaff ER, ed, Neurological Complications of Oral Contraceptives. Oxford: Clarendon Press, 1975; 69–71.
18. Bonnin A, Fernandez-Ruiz JJ, Martin M, Rodriguez de Fonseca F, De Miguel R, Ramos JA. Estrogenic modulation of δ-tetrahydrocannabinol dopaminergic activity in the female rat brain. Mol Cell Neurosci 1992;3:315-325.
19. Cameron DL, Crocker AD. Stimulation of D1dopamine receptors facilitates D2 dopamine receptor recovery after irreversible receptor blockade. Neuropharmacology 1988; 27: 447–450.
20. Casas M, Alvarez E, Duro P, Garcia-Ribera C, Udina C, Velat A, Abella D, Rodriguez-Espinosa J, Salva P, Jane F. Antiandrogenic treatment of obsessive-compulsive neurosis. Acta Psychiatr Scand 1986; 73: 221–222.
21. Casey DE, Keepers GA. Neuroleptic side effects: extrapyramidal syndromes and tardive dyskinesia. Psychopharmacology Ser 1988; 5: 74–93.
22. Centingok M, Chu CC, Park DB. The effect of culture on the sex differences in schizophrenia. Int J Soc Psychiatry 1990; 36: 272–279.
23. Chang SS, Renshaw DC. Psychosis and pregnancy. Compr Ther 1986; 12: 36–41.
24. Crane GE. Tardive dyskinesia in patients treated with major neuroleptics: a review of the literature. Am J Psychiatry (suppl) 1968; 124: 40–48.
25. DeRyck M, Hruska RE, Silbergeld EK. Estrogen and haloperidol-induced versus handling-related catalepsy in male rats. Pharmacol Biochem Behav 1982; 17: 1027–1035.
26. Di Paolo T, Bedard PJ, Dupont A, Poyet P, Labrie F. Effects of estradiol on intact and denervated striatal dopamine receptors and on dopamine levels: a biochemical and behavioral study. Can J Physiol Pharmacol 1982; 60: 350–357.
27. Di Paolo T, Poyet P, Labrie F. Effect of prolactin and estradiol on rat striatal dopamine receptors. Life Sci 1982; 31: 2921–2929.
28. Di Paolo T, Poyet P, Labrie F. Prolactin and estradiol increase striatal dopamine receptor density in intact, castrated and hypophysectomized rats. Prog Neuropsychopharmacol Biol Psychiatry 1982; 6: 377–382.
29. Di Paolo T, Barden N. Effect of estrogen and prolactin on dopamine receptors - Further characterization. In: Woodruff GN, Poat JA, Roberts J, eds, Dopaminergic Systems and Their Regulation. London: MacMillan Press, 1986; 323–337.
30. Di Paolo T, Bédard P, Labrie F. Neuroloptic-like activity of estrogens. In: Pichot P, Berner P, Wolf R, Thau K, eds, Proc VI 1th World Congress of Psychiatry. New York: Plenum Press, 1985; 2: 237–242.
31. Di Paolo T, Bedard P, Labrie F, Barden N. Effect of hormones on brain neurotransmitters. In: Villeneuve A, ed, Brain Neurotransmitters and Psychiatry, Canada: Asta Publications, 1985; 8–19.
32. Di Paolo T, Carmichel R, Labrie F. Effects of estrogens on the characteristics of [3H]spiroperidol and [3H] RU24213 binding in rat anterior pituitary gland and brain. Mol Cell Endocrinol 1979; 16: 99–112.
33. Di Paolo T, Daigle M, Labrie F. Effect of estradiol and haloperidol on hypophysectomized rat brain dopamine receptors. Psychoneuroendocrinology 1984; 9: 399–404.
34. Di Paolo T, Falardeau F. Modulation of brain and pituitary dopamine receptors by estrogens and prolactin. Prog Neuropsychopharmacol Biol Psychiatry 1985; 9: 473–480.
35. Di Paolo T, Falardeau P, Morissette M. Striatal D2 dopamine agonist binding sites fluctuate during the rat estrous cycle. Life Sci 1988; 43: 665–672.
36. Di Paolo T, Levesque D, Daigle M. A physiological dose of progesterone affects rat striatum biogenic amine metabolism. Eur J Pharmacol 1986; 125: 11–16.
37. Di Paolo T, Poyet P, Labrie F. Effect of chronic estradiol and haloperidol treatment on striatal dopamine receptors. Eur J Pharmacol 1981; 73: 105–106.
38. Di Paolo T, Rouillard C, Bedard P. 17β-estradiol at a physiological dose acutely increases dopamine turnover in rat brain. Eur J Pharmacol 1985; 117: 197–203.
39. Donaldson JO. Movement disorders. In: Donaldson JO, ed, Neurology of Pregnancy. Philadelphia: W.B. Saunders Co., 1978; 74–87.
40. Dupont A, Di Paolo T, Mérand Y, Gagné B, Lepine J, Barden N, Labrie F. Biochemical effects of estrogens and thyroid hormones in the CNS. In: Fuxe K, Gustafsson JA, Wetterberg L, eds, Steroid hormone regulation of the brain. Oxford, New York: Pergamon Press, 1981; 217–235.
41. Falardeau P, Di Paolo T. Regional effect of estradiol on rat caudate putamen dopamine receptors: lateral-medial differences. Neurosci Lett 1987; 74: 43–48.
42. Feighner JP, Robins E, Guze SB, Woodruff RA, Winokur G, Munoz R. Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 1972; 26: 57–63.
43. Fernandez-Ruiz JJ, de Miguel R, Hernandez ML, Ramos JA. Time-course of the effects of ovarian steroids on the activity of limbic and striatal dopaminergic neurons in female rat brain. Pharmacol Biochem Behav 1990; 36: 603–606.
44. Fields JZ, Gordon JH. Estrogen inhibits the dopaminergic supersensitivity induced by neuroleptics. Life Sci 1982; 30: 229–234.
45. Flor-Henry P. Influence of gender in schizophrenia as related to other psychopathological syndromes. Schizophr Bull 1990; 16: 211–227.
46. Flor-Henry P. Schizophrenia: sex differences. Can J Psychiatry 1985; 30: 319–322.
47. Freyhan FA. Psychomotility and Parkinsonism in treatment with neuroleptic drugs. Arch Int Neurol 1957; 78: 465–472.
48. Glazer WM, Naftolin F, Morgenstern H, Barnea ER, MacLusky NJ, Brenner LM. Estrogen replacement and tardive dyskinesia. Psychoneuroendocrinology 1985; 10: 345–350.
49. Goldstein JM, Link BG. Gender differences in the clinical expression of schizophrenia. J Psychiatry Res 1988; 22: 141–155.
50. Gomez-Mancilla B, Bédard PJ. Effect of estrogen and progesterone on L-DOPA-induced dyskinesia on MPTP-treated monkeys. Neurosci Lett 1992; 135: 129–132.
51. Gordon JH, Borison RL, Diamond BI. Modulation of dopamine receptor sensitivity by estrogen. Biol Psychiatry 1980; 15: 389–396.
52. Gordon JH, Diamond BI. Antagonism of dopamine supersensitivity by estrogen: neurochemical studies in an animal model of tardive dyskinesia. Biol Psychiatry 1981; 16: 365–371.
53. Gordon JH, Perry KO. Pre- and postsynaptic neurochemical alterations following estrogen-induced striatal dopamine hypo- and hypersensitivity. Brain Res Bull 1983; 10: 425–428.
54. Gouchie C, Kimura D. The relationship between testosterone levels and cognitive ability patterns. Psychoneuroendocrinology 1991; 16: 323–334.
55. Gratton L. Neuroleptiques, Parkinsonisme et schizophrenic. Union Med Can 1960; 89: 679–694.
56. Häfner H, Behrens S, DeVry J, Gattaz WF. Oestradiol enhances the vulnerability threshold for schizophrenia in women by an early effect on dopaminergic neurotransmission. Eur Arch Psychiatry Clin Neurosci 1991; 241: 65–68.
57. Häfner H, Riecher A, Maurer K, Löffler W, Munk-Jorgensen P, Strömgren E. How does gender influence age at first hospitalization for schizophrenia? A transnational case register study. Psychol Med 1989; 19: 903–918.
58. Hampson E, Kimura D. Reciprocal effects of hormonal fluctuations on human motor and perceptual-spatial skills. Beh Neurosci 1988; 102: 456–459.
59. Hampson E. Estrogen-related variations in human spatial and articulartory-motor skills. Psychoneuroendocrinology 1990; 15: 97–111.
60. Harris LJ. Sex-related variations in spatial skill. In: Liben LS, Patterson AH, Newcombe N, eds, Spatial Representation and Behavior Across the Life Span. New York: Academic Press, 1981: 83–125.
61. Harshman RA, Hampson E, Berenbaum SA. Individual differences in cognitive abilities and brain organization -I. Sex and handedness differences in ability. Can J Psychol 1983; 37: 144–192.
62. Hassler M, Gupta D, Woolmann H. Testosterone, estradiol, ACTH and musical, spatial and verbal performance. Int J Neurosci 1992; 65: 45–60.
63. Hruska RE, Ludmer LM, Pitman KT, De Ryck M, Silbergeld EK. Effects of estrogen on striatal dopamine receptor function in male and female rats. Pharmacol Biochem Behavior 1982; 16: 285–291.
64. Hruska RE, Ludmer LM, Silbergeld EK. Characterization of the striatal dopamine receptor supersensitivity produced by estrogen treatment of male rats. Neuropharmacology 1980; 19: 923–926.
65. Hruska RE, Nowak MW. Estrogen treatment increases the density of Drdopamine receptors in the rat striatum. Brain Res 1988; 442: 349–350.
66. Hruska RE, Pitman KT. Distribution and localization of estrogen-sensitive dopamine receptors in the rat brain. J Neurochem 1982; 39: 1418–1423.
67. Hruska RE, Silbergeld EK. Estrogen treatment enhances dopamine receptor sensitivity in the rat striatum. Eur J Pharmacol 1980; 61: 397–400.
68. Hruska RE, Silbergeld EK. Increased dopamine receptor sensitivity after estrogen treatment using the rat rotation model. Science 1980; 208: 1466–1468.
69. Hruska RE. Sex hormone exposure and nonreproductive behavior. Int J Ment Health 1985; 14: 112–134.
70. Jeste DV, Lohr JB, Clarck K, Wyatt RJ. Pharmacological treatment of tardive dyskinesia in the 1980s. J Clin Psychopharmacol 1988; 8 (suppl): 38S-48S.
71. Joyce JN, Loeschen SK, Marshall JF. Dopamine D2 receptors in rat caudate putamen: the lateral to medial gradient does not correspond to dopaminergic innervation. Brain Res 1985; 338: 209–215.
72. Joyce JN. Multiple dopamine receptors and behavior. Neurosci Biobehav Rev 1983; 7: 227–256.
73. Kendell RE, Chalmers JC, Platz C. Epidemiology and puerperal psychoses. Br J Psychiatry 1987; 150: 662–673.
74. Kimura D. How sex hormones boost or cut intellectual ability. Psychology Today 1989; November: 62–66.
75. Koller WC, Barr A, Biary N. Estrogen treatment of dyskinetic disorders. Neurology 1982; 32: 547–549.
76. Komnenich P, Lane DM, Dickey RP, Stone SC. Gonadal hormones and cognitive performance. Physiol Psychol 1978; 6: 115–120.
77. Leckman JF, Scahill L. Possible exacerbation of tics by androgenic steroids. N Engl J Med 1990; 322: 1674.
78. Lehmann HE, Ban TA. Sex differences in long-term adverse effects of phenothiazines. In: Forrest TS, Carr CJ, Usdin E, eds, The phenothiazines and Structurally Related Drugs. New York: Raven Press, 1974; 249–254.
79. Levesque D, Di Paolo T. Rapid conversion of high into low striatal D2 dopamine receptor agonist binding states after an acute physiological dose of 17β-estradiol. Neurosci Lett 1988; 88: 113–118.
80. Levesque D, Di Paolo T. Chronic estradiol treatment increases ovariectomized rat striatal D1 dopamine receptors. Life Sci 1989; 45: 1813–1820.
81. Levesque D, Di Paolo T. Effect of the rat estrous cycle at ovariectomy on striatal D1 dopamine receptors. Brain Res Bull 1990; 24: 281–284.
82. Levesque D, Di Paolo T. Dopamine receptor reappearance after irreversible receptor blockade: effect of chronic estradiol treatment of ovariectomized rats. Mol Pharmacol 1991; 39: 659–665.
83. Lévesque D, Di Paolo T. Modulation by estradiol and progesterone of the GTP effect on striatal D2 dopamine receptors. Biochem Pharmacol 1993; 45: 723–733.
84. Lévesque D, Gagné B, Barden N, Di Paolo T. Chronic estradiol treatment increases anterior pituitary but not striatal D2 dopamine receptor mRNA levels in rats. Neurosci Lett 1992; 140: 5–8.
85. Lévesque D, Gagnon S, Di Paolo T. Striatal D1 dopamine receptor density fluctuates during the rat estrous cycle. Neurosci Lett 1989; 98: 345–350.
86. Lewine RRJ. Schizophrenia: an amotivational syndrome in men. Can J Psychiatry 1985; 30: 316–318.
87. Lewis BV, Parsons M. Chorea Gravidarum. Lancet I 1966; 284–286.
88. Loranger AW. Sex difference in age at onset of schizophrenia. Arch Gen Psychiatry 1984; 41: 157–161.
89. Maccoby EE, Jacklin CN. The psychology of sex differences. Standford, CA: Stanford University Press, 1974.
90. Marneros A. Frequency of occurrence of Schneider’s first rank symptoms in schizophrenia. Eur Arch Psychiatry Neurol Sci 1984; 234: 78–82.
91. Mauger JP, Sladeczek F, Bockaert J. Characteristics and metabolism of al adrenergic receptors in a nonfusing muscle cell line. J Biol Chem 1982; 257: 875–879.
92. McCabe MS. Demographic difference in functional psychoses. Br J Psychiatry 1975; 127: 320–323.
93. McDowell FH, Lee JE, Sweet RD. Extrapyramidal disease, In: Baker AB, Baker LH, eds, Clinical Neurology, vol 2. Philadelphia: Harper and Row.
94. Mishell DR. Contraception. New Engl J Med 1989; 320: 777–787.
95. Morissette M, Di Paolo T. Sex and estrous cycle variations of rat striatal dopamine uptake sites. Neuroendocrinology 1993; 58: 16–22.
96. Morissette M, Garcia-Segura LM, Bélanger A, Di Paolo T. Membrane effects of steroid hormones in the rat striatum: changes during the estrous cycle. Posters in Neuroscience 1991; 1: 95–98.
97. Morissette M, Garcia-Segura LM, Belanger A, Di Paolo T. Changes of rat striatal neuronal membrane morphology and steroid content during the estrous cycle. Neuroscience 1992; 49: 893–902.
98. Morissette M, Levesque D, Belanger A, Di Paolo T. A physiological dose of estradiol with progesterone affects striatum biogenic amines. Can J Physiol Pharmacol 1990; 68: 1520–1526.
99. Morissette M, Levesque D, Di Paolo T. Effect of chronic estradiol treatment on brain dopamine receptor reappearance after irreversible blockade: an autoradiographic study. Mol Pharmacol 1992; 42: 480–488.
100. Morissette M, Di Paolo T. Effect of estradiol and progesterone on rat striatal dopamine uptake sites. Brain Res Bull 1990; 25: 419–422.
101. Naftolin F, Garcia-Segura LM, Keefe D, Leranth C, Maclusky NJ, Brawer JR. Estrogen effects on the synaptology and neural membranes of the rat hypothalamic arcuate nucleus. Biol Reprod 1990; 42: 21–28.
102. Nausieda PA, Koller WC, Weiner WJ, Klawans HL. Chorea induced by oral contraceptives. Neurology 1979; 29: 1605–1609.
103. Nausieda PA, Koller WC, Weiner WJ, Klawans HL. Modification of postsynaptic dopaminergic sensitivity by female sex hormones. Life Sci 1979; 25: 521–526.
104. Nausieda PA, Grossman BJ, Koller WC, Weiner WJ, Klawans HL. Sydenham chorea: an update. Neurology 1980; 30: 331–334.
105. Paul SM, Axelrod J. Catecholestrogens: Presence in brain and endocrine tissues. Science 1977; 197: 657–659.
106. Pauls DL, Pakstis AJ, Kurlan R, Kidd KK, Leckman JF, Cohen JD, Kidd JR, Como P, Sparkes R. Segregation and linkage analyses of Tourette’s Syndrome and related disorders. J Am Acad Child Adolesc Psychiatry 1990; 29: 195–203.
107. Peris J, Decambe N, Coleman-Hardee ML, Simpkins JW. Estradiol enhances behavioral sensitization to cocaine and amphetamine-stimulated striatal [3H]dopamine release. Brain Res 1991; 566: 255–264.
108. Perry KO, Diamond Bl, Fields JZ, Gordon JH. Hypophysectomy induced hypersensitivity to dopamine: antagonism by estrogen. Brain Res 1981; 226: 211–219.
109. Peterson BS, Leckman JF, Scahill L, Naftolin F, Keefe D, Charest NJ, Cohen DJ. Steroid hormones and CNS sexual dimorphisms modulate symptom expression in Tourette’s syndrome. Psychoneuroendocrinology 1992; 17: 553–563.
110. Pich EM, Benfenati F, Farabegoli C, Fuxe F, Meller E, Arosson M, Goldstein M, Agnati LF. Chronic haloperidol affects striatal D2-dopamine reappearance after irreversible receptor blockade. Brain Res 1987; 435: 147–152.
111. Post RM, Contel NR. Human and animal studies of cocaine: implications for development of behavioral pathology. In: Creese I, ed, Stimulant: Neurochemical, Behavioral, and Clinical Perspective. New York: Raven Press, 1983; 169–203.
112. Post RM, Weiss SRB, Pert A, Uhde TW. Chronic cocaine administration: sensitization and kindling effects. In: Fisher S, Raskin A, Uhlenhut EH, eds, Cocaine: Clinical and Biobehavioral Aspects, New York: Oxford University Press, 1987; 109–173.
113. Price RA, Kidd KK, Pauls DL, Cohen DJ, Leckman JF. A twin study of Tourette’s syndrome. Arch Gen Psychiatry 1985; 42: 815–820.
114. Rector NA, Seeman MV. Auditory hallucinations in women and men. Schizophr Res 1992; 7: 233–236.
115. Riecher-Rössler A, Hafner H. Schizophrenia and estrogens - is there an association? Eur Arch Psychiatry Clin Neurosci 1993; 242: 323–328.
116. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 1987; 237: 1219–1223.
117. Seeman MV, Lang M. The role of estrogens in schizophrenia gender differences. Schizophr Bull 1990; 16: 185–194.
118. Simpson GE, Varga E, Lee JH, Zoubok B. Tardive dyskinesia and psychotropic drug history. Psychopharmacology (Berlin) 1978; 58: 117–124.
119. Srivastava LK, Bajuva SB, Johnson RL, Mishra RK. Interaction of L-propyl-L-leucyl glycinamide with dopamine D2 receptor: evidence for modulation of agonist affinity states in bovine striatal membranes. J Neurochem 1988; 50: 960–968.
120. Swedo SE, Rapoport JL. Neurochemical and neuroendocrine considerations of obsessive-compulsive disorders in childhood. In: Deutsch S, ed, Application of Basic Neuroscience to Child Psychiatry. New York: Plenum Press, 1990; 275–284.
121. Tarsy D, Baldessarini RJ. The pathophysiologic basis of tardive dyskinesia. Biol Psychiatry 1977; 12: 431–450.
122. Tepper SJ, Haas JF. Prevalence of tardive dyskinesia. J Clin Psychiatry 1979; 40: 508–516.
123. Toran-Allerand CD, Miranda RC, Hochberg RB, Mac Lusky NJ. Cellular variations in estrogen receptor mRNA translation in the developing brain: evidence from combined [123I] estrogen autoradiography and non-isotopic in situ hybridization histochemistry. Brain Res 1992; 576: 25–41.
124. Van Hartesveldt C, Joyce JN. Effects of estrogen on the basal ganglia. Neurosci Biobehav Rev 1986; 10: 1–14.
125. Villeneuve A, Cazejust T, Cote M. Estrogens in tardive dyskinesia in male psychiatric patients. Neuropsycho-biology 1980; 6: 145–151.
126. Villeneuve A, Langelier P, Bédard P. Estrogens dopamine and dyskinesias. Can Psychiatric Assoc J 1978; 23: 68–70.
127. Watson NV, Kimura D. Nontrivial sex differences in throwing and intercepting: relation to psychometrically-defined spatial functions. Person Individ Diff 1991; 12: 375–385.
128. Wilson JD, Foster DW, eds, Williams Textbook of Endocrinology. W.D. Saunders Company, 8th Ed, 1992.
129. Wittig MA, Peterson AC. Sex related differences in cognitive functioning. New York: Academic Press, 1979.
130. Yassa R, Jeste DV. Gender differences in tardive dyskinesia: a critical review of the literature. Schizophr Bull 1992; 18: 701–715.
131. Zegart KH, Schwartz RH. Chorea gravidarum. Obstet Gynecol 1968; 32: 24–27.